Lung Cancer

Top Story

Many nonelderly cancer survivors alter prescription drug use to save money

Many nonelderly cancer survivors alter prescription drug use to save money
February 21, 2017

Nearly one-third of nonelderly Americans recently diagnosed with cancer change their prescription drug use for financial reasons, according to an analysis published in Cancer.

“Specifically, nonelderly cancer survivors were more likely to skip medication, delay filling a prescription, ask their doctor for lower-cost medication, and use alternative therapies for financial reasons compared with nonelderly individuals without a cancer history,” Ahmedin Jemal, DVM, PhD, vice president of surveillance and health services research at the American Cancer Society, said in a press release.

In the Journals Plus

Genetic sequencing tests show ‘widely discordant’ results

February 21, 2017
Two of the most widely used genetic sequencing tests — FoundationOne and Guardant360 — showed “widely discordant” results in the same patients…
Meeting News

Smoking cessation reduces risk of cancers in people with HIV; lung cancer most stubborn

February 20, 2017
SEATTLE — Just 1 year after quitting smoking, people with HIV face roughly the same risk of acquiring most cancers as those with the virus who had never smoked…

Society leaders: 2017 likely to be time of ‘unprecedented’ advances in hematology, oncology

February 20, 2017
This calendar year could be a pivotal one for oncology and hematology research, drug approvals and clinical trial results. In 2016, several new immunotherapies…
CME

Immuno-Oncology Forum: Focus on Non-Small Cell Lung Cancer

This activity is supported by educational grants from Bristol-Myers Squibb; Genentech, Inc.; and Merck & Co., Inc.

Lung cancer accounts for 27% of all cancer deaths in the United States, making it the leading cause of cancer…
More »
Video
Meeting News Coverage

VIDEO: Diabetes, obesity associated with chemotherapy-induced neuropathy

June 22, 2016
More »
Featured
CME

The Patient with Castration-resistant Prostate Cancer

No commercial support for this activity.

Castration-resistant prostate cancer (CRPC) is a heterogeneous condition that encompasses a continuum of disease…
More »
In the Journals Plus

Many nonelderly cancer survivors alter prescription drug use to save money

February 21, 2017
Nearly one-third of nonelderly Americans recently diagnosed with cancer change their prescription drug use for financial reasons, according to an…

In the Journals Plus

Genetic sequencing tests show ‘widely discordant’ results

February 21, 2017
Two of the most widely used genetic sequencing tests — FoundationOne and Guardant360 — showed “widely discordant” results in…

Meeting News

Smoking cessation reduces risk of cancers in people with HIV; lung cancer most stubborn

February 20, 2017
SEATTLE — Just 1 year after quitting smoking, people with HIV face roughly the same risk of acquiring most cancers as those with the virus who…

Society leaders: 2017 likely to be time of ‘unprecedented’ advances in hematology, oncology

February 20, 2017
This calendar year could be a pivotal one for oncology and hematology research, drug approvals and clinical trial results. In 2016, several new…

Counseling visit impacts patients’ decision to undergo lung cancer screening

February 16, 2017
A centralized counseling and shared decision-making visit impacts patient knowledge of eligibility criteria for lung cancer screening, as well as the…

In the Journals Plus

Stereotactic radiosurgery trial for brain metastases from NSCLC ‘urgently needed’

February 16, 2017
The use of stereotactic radiosurgery followed by epidermal growth factor receptor tyrosine kinase inhibitors resulted in longer OS than other…

In the Journals

Telephone-based counseling after lung cancer screening helps smokers quit

February 14, 2017
Smokers who undergo lung cancer screening and receive both cessation resources and telephone counseling are more likely to quit than those who…

FDA: More adolescents with cancer should be included in adult trials

February 13, 2017
Enrollment of adolescents in oncology trials remains significantly lower than that of children. Consequently, the FDA has urged the research…

In the Journals Plus

Use of metaphors may improve participation in clinical trials

February 11, 2017
The use of metaphors for explaining randomization could ease the difficulty in recruiting patients to participate in randomized clinical trials…

‘Explosive growth’ of interventional oncology prompts formation of new society

February 10, 2017
The board of directors for World Conference on Interventional Oncology, a nonprofit association that supports and promotes the field, has established…

More Headlines »
Advertisement
Advertisement